The activation of TGF-β signaling induced by HMGA2 was shown to occur preferentially at the invasive front of colorectal tumors and in secondary metastatic lesions [35], and in lymph node metastasis of pancreatic adenocarcinoma [36]. This evidence concerns the gene TGFB1 and pancreatic adenocarcinoma.